Lindsay O Neto, MPH1,2, Jennifer A Ruiz, DPT1,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Jodie K Haselkorn, MD, MPH4,5,6,7 and Elizabeth S Gromisch, PhD, MSCS1,3,8, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Epidemiology, University of Washington, Seattle, WA, (8)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

Mitzi Joi Williams, MD1, Todor I. Totev, MBA2, Camilo Obando, MD, MBA3, Monica Doring, BA3, Lindsey Araujo, PhD3, Charles Shinaver, PhD3, Phung Quach, PharmD3, Aditi Shah, MA4, Katherine Milbers, MScPH4, Dominic Pilon, MA4 and Patrick Lefebvre, MA4, (1)Joi Life Wellness Group, LLC, Atlanta, GA, (2)Analysis Group, Inc., Boston, MA, (3)Janssen Scientific Affairs, LLC, Titusville, NJ, (4)Analysis Group, Inc., Montréal, QC, Canada

Sama Bitarafan, MD, phD1,2,3, Salena Bath, B.Sci, MD student2,3 and Galina Vorobeychik, MD, FRCPS(C), FAAN2,3, (1)Tehran University of medical sciences, Neuroscience institute, Iranian center of neurological research, Tehran, Iran (Islamic Republic of), (2)University of British Columbia, Vancouver, BC, Canada, (3)Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada

Shuvro Roy, MD, Janel Haughton, RN and Scott D. Newsome, DO, MSCS, FAAN, FANA, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

Jeffrey L Bennett, MD, PhD, Professor of Neurology and Ophthalmology, University of Colorado, School of Medicine, Anschutz Medical Campus, Aurora, CO, Michael A Smith, PhD, Clinical Development, Horizon Therapeutics, Deerfield, IL, Kristina R Patterson, MD, PhD, Medical Affairs, Horizon Therapeutics plc, Deerfield, IL and Brian G Weinshenker, MD, Neurology, Mayo Clinic, Rochester, MN

Orhan Aktas, MD, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany, Jeffrey L Bennett, MD, PhD, Professor of Neurology and Ophthalmology, University of Colorado, School of Medicine, Anschutz Medical Campus, Aurora, CO, Brian G Weinshenker, MD, Neurology, Mayo Clinic, Rochester, MN, Friedemann Paul, MD, Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité Universitätsmedizin Berlin, Berlin, Germany, Ho Jin Kim, MD, Neurology, Research Institute and Hospital of National Cancer Center, Seoul, Korea, Republic of (South), Hans-Peter Hartung, MD, Heinrich-Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Sydney, NSW, Australia, William B Rees, PhD, Translational Medicine, Horizon Therapeutics plc, Gaithersburg, MD, Dewei She, PhD, Biometrics, Horizon Therapeutics plc, Gaithersburg, MD, Eliezer Katz, MD, FACS, Clinical Development, Horizon Therapeutics plc, Gaithersburg, MD and Bruce A.C. Cree, MD, UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA

Hannah Kelly, BS, Case Western Reserve University School of Medicine, Cleveland, OH, Jessica Johnson, BS, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, Collin Jakubecz, PharmD, Pharmacy, University Hospitals Cleveland Medical Center, Cleveland, OH, Alessandro Serra, MD, PhD, Multiple Sclerosis and Neuroimmunology program, University Hospitals Cleveland Medical Center, Cleveland, OH and Hesham Abboud, MD, PhD, Multiple Sclerosis and Neuroimmunology Program, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH

Joy Gupta, MBA1, Maureen A. Mealy, PhD, RN1 and Michael Levy, MD, PhD2, (1)Medical Affairs, Horizon Therapeutics plc, Deerfield, IL, (2)Division of Neuroimmunology & Neuroinfectious Disease and Department of Neurology, Harvard Medical School and Massachusetts General Hospital, Boston, MA

Ahmed Z Obeidat, MD, Ph.D., Neurology, Medical College of Wisconsin, Milwaukee, WI

Christopher B. Lock, MD, PhD1, Jeffrey A Cohen, MD2, Fred D. Lublin, MD3, Daniel Pelletier, MD4, Tanuja Chitnis, MD5, Munish Mehra, PhD6, Yael Gothelf, Ph.D.7, Revital Aricha, PhD8, Stacy Lindborg, PhD9, Chaim Lebovits, CEO7 and Ralph Kern, MD, MHSc9, (1)Stanford School of Medicine, Palo Alto, CA, (2)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (3)Corinne Goldsmith Dickinson Center for Multiple Sclerosis, New York, NY, (4)Keck School of Medicine of University of Southern California, Los Angeles, CA, (5)Brigham and Women’s Hospital, Boston, MA, (6)Tigermed, Somerset, NJ, (7)R&D, Brainstorm Cell Therapeutics, Petach Tikva, NY, Israel, (8)R&D, Brainstorm Cell Therapeutics, Petach Tikva, Israel, (9)R&D, Brainstorm Cell Therapeutics, New York, NY

Ferhan Qureshi, BS1, Tammy Hoyt, MS2, Angel Christensen, BS2, Fatima Rubio da Costa, PhD1, Victor Gehman, PhD1, Fujun Zhang, MS1, David Hughes, BSN1 and John Foley, MD2, (1)Octave Bioscience, Inc., Menlo Park, CA, (2)Rocky Mountain Multiple Sclerosis Clinic, Salt Lake City, UT

Rachel Zolno, MD, Natalie Schanzer, BA, Kayleigh Lewis, N/A, Connor Keuchel, BA, Siefaddeen Sharayah, MD, Cristina Gaudioso, MD and Soe Mar, MD, Neurology, Washington University in St. Louis, St. Louis, MO

Catherine S Bergmann, Psy.D.1, Daija Jackson, B.S.2, Mary Elizabeth Quig, Ph.D.2, Robert L Kane, PhD, ABPP-CN3, Meagan A. Adamson, FNP-BC4 and James Simsarian, M.D.5, (1)Washington Neuropsychology Research Group, Fairfax, VA, (2)Neuropsychology Associates of Fairfax, Fairfax, VA, (3)University of Maryland School of Medicine, Baltimore, MD, (4)Multiple Sclerosis Center, Neurology Center of Fairfax, Fairfax, VA, (5)Neurology Center of Fairfax, Fairfax, VA

Rachel M Nicholson, M.S. in Clinical Psychology/Current Doctoral Candidate, Neuropsychology Associates of Fairfax, Fairfax, VA; Comprehensive MS Care Center, South Shore Neurologic Associates, P.C., Patchogue, NY

Nora Garland, MSW, LSW, MSCS, Hannah Gilmore, BA, Dina Jacobs, MD, Sona Narula, MD and Vanessa Zimmerman, MSN, RN, MSCN, Neurology, University of Pennsylvania, Philadelphia, PA

Piper Reynolds, BS, Director Healthcare Provider Engagement, National Multiple Sclerosis Society, New York, NY

Andrea Arzt, LCSW, MSCS, Advocacy and Healthcare Access, The National Multiple Sclerosis Society, New York, NY, Amber Landers, PhD, PsyD, Clinical Psychology, Alliant International University, San Franscisco, CA, Katelyn Michtich, MBA, Advocacy and Healthcare Access, National Multiple Sclerosis Society, Southern California & Nevada Chapter, Los Angeles, CA, Rhoda Olkin, PhD, PsyD, Clinical Psychology, Alliant International University, San Francisco, CA, Linda Trettin, PhD, PsyD, Clinical Neuropsychology, Folsom Neurology/Dignity Health, Sacramento, CA and Pearl Werfel, PhD, PsyD, private practice, San Francisco, CA

Aprille Gangi, HS1, Frederick W Foley, Ph.D.2,3, Jennifer A Ruiz, DPT4,5, Heather M DelMastro, MS5,6, Lindsay O Neto, MPH5,6, Zaenab Dhari, MD5,6, Albert C. Lo, MD, PhD5, Aaron P Turner, Ph.D. ABPP (RP)7,8,9, Thomas P Agresta, MD, MBI10,11 and Elizabeth S Gromisch, PhD, MSCS4,5,12, (1)Trinity College, Hartford, CT, (2)Holy Name Medical Center, Teaneck, NJ, (3)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (4)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (5)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (6)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (7)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (8)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (9)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (10)Department of Family Medicine, University of Connecticut Health Center, Farmington, CT, (11)Center for Quantitative Medicine, University of Connecticut Health Center, Farmington, CT, (12)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

Catherine S Bergmann, Psy.D., Washington Neuropsychology Research Group, Fairfax, VA, Mary Elizabeth Quig, Ph.D., Neuropsychology Associates of Fairfax, Fairfax, VA, Robert L Kane, PhD, ABPP-CN, University of Maryland School of Medicine, Baltimore, MD, Meagan A. Adamson, FNP-BC, Multiple Sclerosis Center, Neurology Center of Fairfax, Fairfax, VA and James Simsarian, M.D., Neurology Center of Fairfax, Fairfax, VA

Grace E Tworek, Psy.D.1, Alexa Kane, PsyD1, Nicolas Thompson, M.S.2 and Amy Sullivan, Psy.D.1, (1)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (2)Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH

Jaklin Gukasyan, B.A., Keck School of Medicine of USC, Los Angeles, CA, Kimberly Gokoffski, MD, PhD, Ophthalmology, Keck School of Medicine of USC, Los Angeles, CA, Alexander Brandt, MD, Neurology, University of California, Irvine, School of Medicine, Irvine, CA and Lilyana Amezcua, MD, Keck School of Medicine, University of Southern California, Los Angeles, CA

Alexandra Jackson, PhD Candidate, Rebekah Sandhu, PhD Student and Marcia Finlayson, PhD, School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada

Alice E Dias, Dr1, Gisele R Barboza, Social Worker2, Gecila AF Santos, Social Worker3 and Priscila S Santos, Social Worker2, (1)Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (2)Social Service, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (3)Social Service, Brazilian Multiple Sclerose Association (ABEM), São Paulo, Brazil

Amber Salter, PhD, Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, Alexander Keenan, MA, MHP, Janssen Scientific Affairs, LLC, Titusville, NJ, Hoa H. Le, PhD, Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ, Kavita Gandhi, MS, Janssen Global Market Access, LLC, Titusville, NJ, Michele Cole, PharmD, MS, Research and Development, Janssen Pharmaceuticals, Titusville, NJ, Maria Ait-Tihyaty, PhD, Janssen Global Medical Affairs, LLC, Titusville, NJ, Samantha Lancia, MS, Biostatistics, Washington University School in St. Louis, School of Medicine, St Louis, MO and Robert J Fox, MD, Mellen Center for Treatment and Research in Multiple Sclerosis, Cleveland Clinic, Cleveland, OH

Anthony Cordisco, MA, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA and Christopher Perrone, MD, Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

Bonnie Blain, RN, CNN(C) MSCN1, Lou-Anne Robertson, RN BScN2, Siobhan Bast, RN BScN MSCN2, Victoria Christiansen, BScAHN RD2, Diana Ehlers, Data Analyst2, Ashley A Hunter, Bachelor of Social Work3, Cassandra Stewart, BA, MScOT, Reg. OT (AB)2 and Golda Catalon, BScOT2, (1)Medical Specialty Clinic, Red Deer Regional Hospital Centre, Alberta Health Services, Red Deer, AB, Canada, (2)Central Alberta MS Clinic, Red Deer, AB, Canada, (3)Medical Specialty Clinic, Alberta Health Services, Red Deer, AB, Canada

Pamela K Newland, PhD, RN, Goldfarb School of Nursing, St Louis, IL, Ling Chen, PhD, Washington University St Louis, St Louis, MO and Brant J. Oliver, PhD, MS, MPH, APRN-BC, Geisel School of Medicine at Dartmouth, Lebanon, NH

Camila Ishueva, BS and Ahmed Z Obeidat, MD, Ph.D., Neurology, Medical College of Wisconsin, Milwaukee, WI

Clara Wan, BA, University of Alabama at Birmingham, Birmingham, AL, Kendall Curtis, BS, University of Pittsburg, Pittsburg, PA, William Meador, MD, Neurology, UAB, Birmingham, AL and John R Rinker, MD, Neurology, University of Alabama at Birmingham, Birmingham, AL

Pengcheng Xun, PhD1, Natalia Sadetsky, MD, PhD2, Kiren Kresa-Reahl, MD1, Sasha Bogdanovich, MD, PhD1, Arie Barlev, PharmD, MS2 and Crystal Watson, MS2, (1)Atara Biotherapeutics, Thousand Oaks, CA, (2)Atara Biotherapeutics, South San Francisco, CA

Daija Jackson, M.A.1, Rachel Nicholson, M.A.2, Catherine S Bergmann, Psy.D.3, Jeffrey Wilken, PhD4, Olivia Kaczmarek, BS5, Barbara Bumstead, MS, ANP-C, MSCN5, Marijean Buhse, NP-C, PhD6, Myassar Zarif, MD6 and Mark Gudesblatt, MD7, (1)The Chicago School of Professional Psychology, Washington, DC, (2)Immaculata University, Immaculata, PA, (3)Washington Neuropsychology Research Group, Fairfax, VA, (4)Washington Neuropsychology Research Group, Washington, DC, (5)South Shore Neurologic Associates, Patchogue, NY, (6)South Shore Neurologic Associates, P.C., Patchogue, NY, (7)South Shore Neurologic Associates, P.C., Islip, NY

Dana Jones, NP1, Anthony M Iuso, DO2, Joseph Sarni, n/a3, Karen Blitz, DO4, Frederick W Foley, Ph.D.5 and Mary Ann Picone, MD1, (1)Holy Name Medical Center, Teaneck, NJ, (2)Clinical Research, Holy Name Medical Center, Teaneck, NJ, (3)NJ, (4)South Shore Neurologic Associates, Patchogue, NY, (5)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY

Derrick S Robertson, MD1, Gabriel Pardo, MD, FAAN2, Mitzi J Williams, MD3, Joseph R Berger, MD, FACP, FAAN, FANA4, David Meyer, MD, MBA5, Daniel S Bandari, MD, MS6, Harold Moses, MD7, Fernando X Cuascut, MD, MPH8, Alexis Jameson, BA9, Jeffrey Carter, PhD9, Laura Simone, PhD9 and Larissa Jarzylo, PhD9, (1)Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, (2)MS Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK, (3)Joi Life Wellness, MS Neurology Center, Smyrna, GA, (4)Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (5)Wake Forest Baptist Health, Winston-Salem, NC, (6)Multiple Sclerosis Center of California and Research Group, Laguna Hills, CA, (7)Department of Neurology, Neuroimmunology Division, Vanderbilt University Medical Center, Nashville, TN, (8)Baylor College of Medicine, Houston, TX, (9)PRIME Education, Fort Lauderdale, FL

Annalise Lowy, PT/s, Andrew Faria, PT/s, Kirsten Sjogren, PT/s, Cameron Watson, PT/s and Erin M Faraclas, PT, DPT, PhD, MSCS, School of Physical Therapy, Massachusetts College of Pharmacy and Health Sciences, Worcester, MA

Heather M DelMastro, MS1,2, Jennifer A Ruiz, DPT1,3 and Lindsay O Neto, MPH1,2, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT

Heather M DelMastro, MS1,2, Elizabeth S Gromisch, PhD, MSCS1,3,4, Lindsay O Neto, MPH1,2 and Jennifer A Ruiz, DPT1,4, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (3)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (4)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT

Jacqueline A Nicholas, MD, MPH1, deMauri S Mackie, PhD2, Halley Costantino, MS2, Lori A Lebson, PhD3, Emily Mulvihill, BS, MBA2 and Amy L Phillips, PharmD4, (1)OhioHealth Multiple Sclerosis Center, Columbus, OH, (2)Cerner Enviza, Malvern, PA, (3)EMD Serono, Rockland, MA, (4)North American Evidence and Value Development, EMD Serono, Rockland, MA

Jacqueline A Nicholas, MD, MPH1, deMauri S Mackie, PhD2, Halley Costantino, MS2, Lori A Lebson, PhD3, Emily Mulvihill, BS, MBA2 and Amy L Phillips, PharmD4, (1)OhioHealth Multiple Sclerosis Center, Columbus, OH, (2)Cerner Enviza, Malvern, PA, (3)EMD Serono, Rockland, MA, (4)North American Evidence and Value Development, EMD Serono, Rockland, MA

Nidhila Masha, B.S.1, Simon Gregory, PhD2, James Giarraputo, B.S.1, Farren B.S. Briggs, PhD, ScM3, Sabrina Cote, PhD4 and Suma Shah, MD5, (1)Duke University School of Medicine, Durham, NC, (2)Duke University, Durham, NC, (3)Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, (4)Durham, NC, (5)Department of Neurology, Duke University, Durham, NC

Salena Bath, BSc, MD Student, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Neurology, Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada